A new study led by Yaffe Lab-affiliated UCSF postdoctoral researcher Matthew Growdon, MD, MPH, sought to assess attitudes toward deprescribing in people with dementia (PWD). Investigators found that a majority of PWD are willing to deprescribe, representing an opportunity to improve quality of life for this vulnerable population.

Read more here.